Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48‐month longitudinal cohort study
KB Sims(Massachusetts General Hospital), Daniel I. Rosenthal(Massachusetts General Hospital), Seymour Packman(University of California, San Francisco), NJ Weinreb(University Research Co (United States)), Ramnik J. Xavier(Broad Institute), MA Fitzpatrick(SynZyme Technologies (United States)), Paige Kaplan(Children's Hospital of Philadelphia), BE Rosenbloom(Tower Cancer Research Foundation), Jennifer Angell, Henry J. Mankin(Harvard University), J. A. Barranger(University of Pittsburgh), GM Pastores(New York University)
Cited by 134
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
A single-cell survey of the small intestinal epithelium
|Nature|2017|1.9k
Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase
|Nature Genetics|1993|1.4k
Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease
|Proceedings of the National Academy of Sciences|2010|661